Translational & Clinical Research Scientist
Postdoctoral Scholar
VCU Parkinson's & Movement Disorders Center
Department of Neurology, Virginia Commonwealth University
Precision medicine for neurodegenerative diseases through biomarker integration and computational methods
My research aims to improve care for patients with Parkinson's disease, Lewy body dementia, and Alzheimer's disease through precision medicine approaches. Disease-modifying trials often struggle because heterogeneous populations are treated as uniform entities. I work to address this challenge by integrating multimodal biomarkers—neuroimaging, EEG, fluid biomarkers—to help stratify patients into biologically meaningful subtypes.
Developing EEG-based biomarkers for cognitive fluctuations using NASA's Psychomotor Vigilance Test combined with resting-state and task-based EEG. Developed an MRI-based approach to subtype PD-MCI based on cholinergic nucleus 4 degeneration markers.
Extended the Alzheimer's ATN framework to include Memory impairment (ATNM) and synuclein-vascular components (ATN-SV). Integrates α-synuclein quantification, plasma biomarkers, and MRI vascular measures for pathology classification.
Conducted comprehensive analysis of PD progression across clinical, pathological, and data-driven subtypes using 10-year PPMI data. Developed disease-duration-specific percentiles for prospective diffuse-malignant identification at diagnosis.
Open-source tools developed for clinical neuroscience research
Online calculator for predicting striatal volumes in Huntington's Disease patients using demographic and clinical variables, enabling pre-screening for clinical trials of intrastriatal gene therapies.
Convolutional neural network for automated detection of Parkinson's Disease from healthy controls using structural T1-weighted MRI data with high cross-validated classification performance.
Feature extraction toolbox for extracting dominant frequency features from EEG signals in patients with neurodegenerative diseases. Enables biomarker development for cognitive fluctuations.
Imaging-based subtype tool for PD-MCI using cholinergic nucleus 4 (NBM) gray matter density. Helps identify patients with cholinergic vulnerability markers for treatment selection.
Interactive tool for clinical, pathological, and data-driven subtyping of Parkinson's Disease. Comprehensive framework integrating 10-year longitudinal data for precision medicine.
Comprehensive pipelines for structural, functional, and diffusion MRI analysis including VBM, cortical thickness, DTI-ALPS for glymphatic function, and multimodal integration.
Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD. Advanced training in Alzheimer's and related dementias clinical trial design and methodology.
Research on cognitive fluctuations in Lewy Body Dementia, multimodal biomarker integration, and precision medicine. Mentors: Matthew J. Barrett, MD, MSc and Brian D. Berman, MD, MS.
Assessed global neurological care delivery systems across 50+ countries. Quantified social determinants of neurological health disparities using advanced geospatial modeling.
Dissertation: "The Hope and the Hype in Parkinson's Disease Treatments" — Meta-research, evidence synthesis, and critical appraisal of neuroprotective interventions.
Evaluated deep brain stimulation outcomes in Parkinson's and Huntington's disease patients using advanced statistical methods.
Medical degree with Very Good grade. Foundation in clinical medicine and early research experience.
Contributing to research education and training
Founded in 2015, Negida Research Academy is a global virtual training platform delivering comprehensive research education. The Academy conducts two structured cohort-based training camps annually, each training approximately 1,200 researchers over 8-12 weeks.
Comprehensive curricula covering research design, biostatistics, data analysis, systematic reviews, meta-analysis, scientific writing, and grant preparation. Multiple mentees have secured competitive fellowships at Harvard Medical School, Cleveland Clinic, Yale, and Duke University.
Visit Negida Academy →Co-founded an international network of neurosurgeons, neurologists, and neuroscientists across 50+ countries. Contributed to the design and execution of GNS-1: a multicenter global traumatic brain injury study with 2,000+ patients across 20+ countries.
IMPACT-AD Fellowship (NIA/NIH, 2025) · U.S. Permanent Residency via EB-2 National Interest Waiver in Biomedical Sciences · Sigma Xi Scientific Honor Society · Multiple international travel grants and awards from professional societies across USA, Europe, Singapore, Canada, and Korea.
Guidelines Committees: North American Neuromodulation Society · European Association of Neurosurgical Societies
Editorial Boards: Frontiers in Neurology (Dementia & Neurodegenerative Disease) · PLOS ONE · Current Neuropharmacology · Medicine
Memberships: International Parkinson's and Movement Disorder Society · American Academy of Neurology · International and North American Neuromodulation Societies · Sigma Xi
Parkinson's and Movement Disorders Center
Department of Neurology
Virginia Commonwealth University
Richmond, VA, USA
Through DataCliNiX, I offer research consultation services including study design, statistical analysis, neuroimaging analysis, systematic reviews, meta-analysis, medical writing, and clinical research training.